环甲膜联合喉室入路切除T1B声门型喉癌临床疗效分析

目的探讨环甲膜联合喉室入路切除T1b声门型喉癌的疗效。方法回顾性分析16例声门型喉癌(T1bN0M013例、T1bN1M03例)患者的临床资料,手术采用环甲膜联合喉室入路切除肿瘤,室带下拉修复声带,带状肌肌膜内翻扩大喉腔,分析术后随访复发情况、拔管率、声嘶情况、声门形态、吞咽情况等。结果16例患者中除1例术后局部复发外,其余随访至今均无复发,拔管率100%,声嘶均有不同程度改善,声门形态接近正常三角形,患者术后第5天开始进食。结论对于T1b声门型喉癌,采用环甲膜联合喉室入路能直视下彻底切除肿瘤、保存喉功能,安全有效。

Excision of T1B glottic carcinoma using the combined approach of cricothyroid membrane and laryngeal ventricle

Objective This study aimed to explore the curative effect of glottic laryngeal carcinoma excision by the combined approach of cricothyroid membrane and laryngeal ventricle. Methods The clinical data of 16 patients with glottic carcinoma(T1bN0M013, T1bN1M03)were retrospectively analyzed. The tumor was excised using the combined approach of cricothyroid membrane and laryngeal ventricle, and the vocal cords were repaired by pulling down the ventricular zone. The recurrent rate, the extubation rate, hoarseness, glottis morphology, and swallowing were analyzed. Results Of the 16 patients, only one patient developed local recurrence after surgery. The extubation rate was 100%. In all patients, the hoarseness improved to different degrees, the morphology of the glottis was close to the normal triangle, and the patients started to eat on day 5 postoperatively. Conclusion The combined approach of cricothyroid membrane and laryngeal ventricle is safe and effective for T1B glottic carcinoma.